Search research articles
Contact Us
Filters
Showing results (61-70 of 67) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 67 results.
Fetal Diagnosis and Therapy
|
March 1, 1995
Midtrimester thoracoamniotic shunting for the treatment of fetal hydrops
R J Morrow, S Macphail, J A Johnson, et al.
Transplantation Proceedings
|
March 1, 1980
Antitumor cytotoxic T cells and non-T-cells generated by allosensitization in vitro
F H Bach, P A Paciucci, S Macphail, et al.
Clinical Immunology and Immunopathology
|
September 1, 1995
The HIV glycoprotein gp 160 has superantigen-like properties
P N Akolkar, B Gulwani-Akolkar, N Chirmule, et al.
Scandinavian Journal of Immunology
|
May 1, 1995
V beta-specific activation of T cells by the HIV glycoprotein gp 160
P N Akolkar, N Chirmule, B Gulwani-Akolkar, et al.
Annals of the New York Academy of Sciences
|
July 7, 1995
V beta-specific activation of T-cells by the HIV glycoprotein gp160
P N Akolkar, B Gulwani-Akolkar, N Chirmule, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 30, 1998
Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent
J A Martiney, A J Rajan, P C Charles, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 17, 1999
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
F M Batliwalla, B A Bateman, D Serrano, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 67) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 67 results.
Fetal Diagnosis and Therapy
|
March 1, 1995
Midtrimester thoracoamniotic shunting for the treatment of fetal hydrops
R J Morrow, S Macphail, J A Johnson, et al.
Transplantation Proceedings
|
March 1, 1980
Antitumor cytotoxic T cells and non-T-cells generated by allosensitization in vitro
F H Bach, P A Paciucci, S Macphail, et al.
Clinical Immunology and Immunopathology
|
September 1, 1995
The HIV glycoprotein gp 160 has superantigen-like properties
P N Akolkar, B Gulwani-Akolkar, N Chirmule, et al.
Scandinavian Journal of Immunology
|
May 1, 1995
V beta-specific activation of T cells by the HIV glycoprotein gp 160
P N Akolkar, N Chirmule, B Gulwani-Akolkar, et al.
Annals of the New York Academy of Sciences
|
July 7, 1995
V beta-specific activation of T-cells by the HIV glycoprotein gp160
P N Akolkar, B Gulwani-Akolkar, N Chirmule, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
May 30, 1998
Prevention and treatment of experimental autoimmune encephalomyelitis by CNI-1493, a macrophage-deactivating agent
J A Martiney, A J Rajan, P C Charles, et al.
Molecular Medicine (Cambridge, Mass.)
|
February 17, 1999
A 15-year follow-up of AJCC stage III malignant melanoma patients treated postsurgically with Newcastle disease virus (NDV) oncolysate and determination of alterations in the CD8 T cell repertoire
F M Batliwalla, B A Bateman, D Serrano, et al.
Page
of 7